Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.

Corbière V, Pottier G, Bonkain F, Schepers K, Verscheure V, Lecher S, Doherty TM, Locht C, Mascart F.

PLoS One. 2012;7(8):e43285. doi: 10.1371/journal.pone.0043285. Epub 2012 Aug 17.

2.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.

BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.

3.

Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.

Wyndham-Thomas C, Corbière V, Dirix V, Smits K, Domont F, Libin M, Loyens M, Locht C, Mascart F.

Clin Vaccine Immunol. 2014 Mar;21(3):321-8. doi: 10.1128/CVI.00651-13. Epub 2014 Jan 3.

4.

Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.

Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, Debrie AS, Doherty TM, Van Vooren JP, Locht C, Mascart F.

PLoS One. 2007 Oct 3;2(10):e926.

5.

Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients.

Dessein R, Corbière V, Nortier J, Dratwa M, Gastaldello K, Pozdzik A, Lecher S, Grandbastien B, Locht C, Mascart F.

PLoS One. 2013 Aug 5;8(8):e71088. doi: 10.1371/journal.pone.0071088. Print 2013.

6.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
7.

Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.

Schepers K, Dirix V, Mouchet F, Verscheure V, Lecher S, Locht C, Mascart F.

Vaccine. 2015 Feb 18;33(8):1077-83. doi: 10.1016/j.vaccine.2014.12.011. Epub 2015 Jan 9.

PMID:
25583385
8.

[Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].

Kuś J, Demkow U, Lewandowska K, Korzeniewska-Koseła M, Rabczenko D, Siemion-Szcześniak I, Białas-Chromiec B, Bychawska M, Sapigórski P, Maciejewski J.

Pneumonol Alergol Pol. 2011;79(6):407-18. Polish.

9.

Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.

Nenadić N, Kirin BK, Letoja IZ, Plavec D, Topić RZ, Dodig S.

Pediatr Pulmonol. 2012 Apr;47(4):401-8. doi: 10.1002/ppul.21555. Epub 2011 Sep 7.

PMID:
21901862
10.

Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.

Place S, Verscheure V, de San N, Hougardy JM, Schepers K, Dirix V, Dediste A, Michel O, Drowart A, Allard SD, Doherty TM, Lecher S, Locht C, Mascart F.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):848-54. doi: 10.1164/rccm.201001-0083OC. Epub 2010 May 27.

PMID:
20508213
11.

Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.

Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, Molicotti P, Zanetti S, Lauria FN, Grisetti S, Magnavita N, Fadda G, Girardi E, Goletti D.

PLoS One. 2011 Mar 29;6(3):e18315. doi: 10.1371/journal.pone.0018315.

12.

Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.

Alsleben N, Ruhwald M, Rüssmann H, Marx FM, Wahn U, Magdorf K.

Scand J Infect Dis. 2012 Apr;44(4):256-62. doi: 10.3109/00365548.2011.632644. Epub 2011 Nov 21.

PMID:
22103555
13.

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.

Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, Meraviglia S, Guggino G, Dieli F, Vecchi M, Lauria FN, Marruchella A, Laurenti P, Singh M, Caccamo N, Girardi E, Goletti D.

BMC Infect Dis. 2009 Nov 21;9:182. doi: 10.1186/1471-2334-9-182.

14.

Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.

Kobashi Y, Shimizu H, Ohue Y, Mouri K, Obase Y, Miyashita N, Oka M.

Lung. 2010 Aug;188(4):283-7. doi: 10.1007/s00408-010-9238-3. Epub 2010 Apr 27.

15.

Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.

Chiappini E, Della Bella C, Bonsignori F, Sollai S, Amedei A, Galli L, Niccolai E, Del Prete G, Singh M, D'Elios MM, de Martino M.

PLoS One. 2012;7(9):e46041. doi: 10.1371/journal.pone.0046041. Epub 2012 Sep 28.

16.

Interferon gamma release assays: principles and practice.

Lalvani A, Pareek M.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Review.

PMID:
19783328
17.

Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.

Schepers K, Mouchet F, Dirix V, De Schutter I, Jotzo K, Verscheure V, Geurts P, Singh M, Van Vooren JP, Mascart F.

Clin Vaccine Immunol. 2014 Feb;21(2):111-8. doi: 10.1128/CVI.00525-13. Epub 2013 Oct 23.

18.

Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection.

Goletti D, Butera O, Vanini V, Lauria FN, Lange C, Franken KL, Angeletti C, Ottenhoff TH, Girardi E.

Eur Respir J. 2010 Jul;36(1):135-42. doi: 10.1183/09031936.00140009. Epub 2009 Nov 19.

19.

In vitro immunomodulation of a whole blood IFN-γ release assay enhances T cell responses in subjects with latent tuberculosis infection.

Gaur RL, Suhosk MM, Banaei N.

PLoS One. 2012;7(10):e48027. doi: 10.1371/journal.pone.0048027. Epub 2012 Oct 29.

20.

Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, Locht C, Mascart F.

Am J Respir Crit Care Med. 2007 Aug 15;176(4):409-16. Epub 2007 May 31.

PMID:
17541018
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk